Medication Deferral List

DO NOT STOP taking medications prescribed by your doctor in order to donate blood.

Donating while taking these drugs could have a negative effect on your health or on the health of the recipient of your blood.

PLEASE TELL US IF YOU...

Are being treated with ANY of the
following types of medications...
or have taken... which is also called... any time in the last...
Anti-platelet agents (usually taken to prevent stroke or heart attack) Feldene piroxicam 2 days
Effient prasugrel 3 days
Brilinta ticagrelor 7 days
Plavix clopidogrel 14 days
Ticlid ticlopidine
Zontivity vorapaxar 1 month
Anticoagulants or “blood thinners” (usually taken to prevent blood clots in the legs and lungs and to prevent strokes) Arixtra fondaparinux 2 days
Eliquis apixaban
Fragmin dalteparin
Lovenox enoxaparin
Pradaxa dabigatran
Savaysa edoxaban
Xarelto rivaroxaban
Coumadin
Warfilone
Jantoven
warfarin 7 days
Heparin, low molecular weight
Acne treatment Accutane
Amnesteem
Absorica
Claravis
Myorisan
Sotret
Zenatane
isotretinoin 1 Month
Multiple myeloma Thalomid thalidomide
Rheumatoid arthritis Rinvoq upadacitinib
Hair loss remedy Propecia finasteride
Prostate symptoms Proscar finasteride
Avodart
Jalyn
dutasteride 6 Months
Immunosuppressant Cellcept mycophenolate mofetil 6 weeks
HIV Prevention (PrEP and PEP) Truvada, Descovy, Tivicay, Isentress Tenofovir, emtricitabine, dolutegravir, raltegravir 3 months
Apretude-injectable HIV prevention cabotegravir 2 years
Basal cell skin cancer Erivedge
Odomzo
vismodegib
sonidegib
Relapsing multiple sclerosis Aubagio teriflunomide
Rheumatoid arthritis Arava leflunomide
Hepatitis exposure Hepatitis B Immune Globulin HBIG 12 months
Experimental Medication or Unlicensed (Experimental) Vaccine
Psoriasis Soriatane acitretin 3 years
Tegison etretinate Ever
HIV treatment also known as antiretroviral therapy (ART) Ever

DO NOT STOP taking medications prescribed by your doctor in order to donate blood.

Some medications affect your eligibility as a blood donor for the following reasons:

Anti-platelet agents affect platelet function, so people taking these drugs should not donate platelets for the indicated time. You may still be able to donate whole blood or red blood cells by apheresis.

Anticoagulants or "blood thinners" are used to treat or prevent blood clots in the legs, lungs, or other parts of the body, and to prevent strokes. These medications affect the blood’s ability to clot, which might cause excessive bruising or bleeding when you donate; however, you may still be able to donate whole blood or red blood cells by apheresis.

Isotretinoin, finasteride, dutasteride acitretin and etretinate can cause birth defects. Your donated blood could contain high enough levels to damage the unborn baby if transfused to a pregnant woman.

Thalomid (thalidomide), Erivedge (Vismodegib), Odomzo (sonidegib), Aubagio (teriflunomide), and Rinvoq (upadacitinib) may cause birth defects or the death of an unborn baby if transfused to a pregnant woman.

Cellcept (mycophenolate mofetil) and Arava (leflunomide) are immunosuppressants that may cause birth defects or the death of an unborn baby if transfused to a pregnant woman.

PrEP or pre-exposure prophylaxis involves taking a specific combination of medicines as a prevention method for people who are HIV negative and at high risk of HIV infection.

PEP or post-exposure prophylaxis is a short-term treatment started as soon as possible after a high-risk exposure to HIV to reduce the risk of infection.

ART or antiretroviral therapy is the daily use of a combination of HIV medicines (called an HIV regimen) to treat HIV infection.

Hepatitis B Immune Globulin (HBIG) is an injected material used to prevent hepatitis B infection following a possible or known exposure to hepatitis B. HBIG does not prevent hepatitis B infection in every case, therefore, persons who have received HBIG must wait to donate blood.

Experimental Medication or Unlicensed (Experimental) Vaccine is usually associated with a research study, and the effect on the safety of transfused blood is unknown.

Legacy Doc No: 15.4.fs401 Rev#: 4